Simvastatin Inhibits LPS-induced Alveolar Bone Loss during Metabolic Syndrome

Studies in recent years have shown a positive relationship between metabolic syndrome (MS) and periodontal disease (PD). Given that patients with MS take statins to reduce cholesterol, and statins also have anti-inflammatory effects, it is important to determine if statin intake hinders the progress...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jin, J., Machado, E.R., Yu, H., Zhang, X., Lu, Z., Li, Y., Lopes-Virella, M.F., Kirkwood, K.L., Huang, Y.
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2014
Sujets:
Research Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3929976/
https://ncbi.nlm.nih.gov/pubmed/24352501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034513516980
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires